Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2020 Filed Mar 5, 2020 00:17 UTC |
Dorer Benno ODirector · Chair & CEO
|
SaleCommon Stock | 94,411 | $169.03 | $15,957,989.21 |
DisclosureSEC source: 0001225208-20-004377 · doc4.xml · nonDerivative · entry 9 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,495 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/2/2019, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F8 · price: This transaction was executed in multiple trades at prices ranging from $168.3850 to $169.3850. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:17 UTC |
Dorer Benno ODirector · Chair & CEO
|
SaleCommon Stock | 24,048 | $167.87 | $4,036,875.24 |
DisclosureSEC source: 0001225208-20-004377 · doc4.xml · nonDerivative · entry 8 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 293,906 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/2/2019, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F7 · price: This transaction was executed in multiple trades at prices ranging from $167.3800 to $168.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:17 UTC |
Dorer Benno ODirector · Chair & CEO
|
SaleCommon Stock | 14,441 | $170.62 | $2,463,972.52 |
DisclosureSEC source: 0001225208-20-004377 · doc4.xml · nonDerivative · entry 7 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,954 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/2/2019, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F6 · price: This transaction was executed in multiple trades at prices ranging from $170.3900 to $171.2600. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:17 UTC |
Dorer Benno ODirector · Chair & CEO
|
SaleCommon Stock | 13,250 | $166.80 | $2,210,065.55 |
DisclosureSEC source: 0001225208-20-004377 · doc4.xml · nonDerivative · entry 6 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,395 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/2/2019, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F5 · price: This transaction was executed in multiple trades at prices ranging from $166.3400 to $167.3100. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:17 UTC |
Dorer Benno ODirector · Chair & CEO
|
SaleCommon Stock | 5,844 | $165.92 | $969,649.92 |
DisclosureSEC source: 0001225208-20-004377 · doc4.xml · nonDerivative · entry 5 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,645 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/2/2019, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F4 · price: This transaction was executed in multiple trades at prices ranging from $165.3300 to $166.2650. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:17 UTC |
Dorer Benno ODirector · Chair & CEO
|
SaleCommon Stock | 4,201 | $163.39 | $686,413.57 |
DisclosureSEC source: 0001225208-20-004377 · doc4.xml · nonDerivative · entry 4 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,489 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/2/2019, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F3 · price: This transaction was executed in multiple trades at prices ranging from $162.9550 to $163.9500. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:17 UTC |
Dorer Benno ODirector · Chair & CEO
|
SaleCommon Stock | 1,998 | $164.53 | $328,724.15 |
DisclosureSEC source: 0001225208-20-004377 · doc4.xml · nonDerivative · entry 3 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,690 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/2/2019, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F2 · price: This transaction was executed in multiple trades at prices ranging from $164.0150 to $164.9100. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:17 UTC |
Dorer Benno ODirector · Chair & CEO
|
Exercise / conversionCommon Stock | 50,780 | $89.82 | $4,561,059.60 |
DisclosureSEC source: 0001225208-20-004377 · doc4.xml · nonDerivative · entry 2 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/2/2019, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:17 UTC |
Dorer Benno ODirector · Chair & CEO
|
Exercise / conversionCommon Stock | 221,170 | $100.24 | $22,170,080.80 |
DisclosureSEC source: 0001225208-20-004377 · doc4.xml · nonDerivative · entry 1 Dorer Benno O · CIK 0001456667 · Director · Chair & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on 12/2/2019, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:14 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
SaleCommon Stock | 870 | $170.00 | $147,900.00 |
DisclosureSEC source: 0001225208-20-004376 · doc4.xml · nonDerivative · entry 1 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 2,178 Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:13 UTC |
Costello Michael R.SVP - General Manager
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,830 | $0.00 Strike: $89.82 | $0.00 |
DisclosureSEC source: 0001225208-20-004375 · doc4.xml · derivative · entry 4 Costello Michael R. · CIK 0001514868 · SVP - General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,830 shares Expires 2024-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:13 UTC |
Costello Michael R.SVP - General Manager
|
SaleCommon Stock | 19,360 | $169.43 | $3,280,234.50 |
DisclosureSEC source: 0001225208-20-004375 · doc4.xml · nonDerivative · entry 2 Costello Michael R. · CIK 0001514868 · SVP - General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,129.2808 F1 · price: This transaction was executed in multiple trades at prices ranging from $169.20 to $169.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2020 Filed Mar 5, 2020 00:13 UTC |
Costello Michael R.SVP - General Manager
|
Exercise / conversionCommon Stock | 20,830 | $89.82 | $1,870,950.60 |
DisclosureSEC source: 0001225208-20-004375 · doc4.xml · nonDerivative · entry 1 Costello Michael R. · CIK 0001514868 · SVP - General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,489.2808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Apr 2, 2020 20:19 UTC |
WILLIAMS CHRISTOPHER JDirector
|
GrantDeferred Stock Units · Derivative | 53.7046 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-005938 · doc4.xml · derivative · entry 1 WILLIAMS CHRISTOPHER J · CIK 0001269949 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,404.7723 Underlying: Common Stock · 53.7046 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 14, 2020 Filed Apr 2, 2020 20:19 UTC |
WEINER RUSSELL JDirector
|
GrantDeferred Stock Units · Derivative | 31.3782 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-005937 · doc4.xml · derivative · entry 1 WEINER RUSSELL J · CIK 0001622458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,910.6953 Underlying: Common Stock · 31.3782 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 14, 2020 Filed Apr 2, 2020 20:19 UTC |
Shattock Matthew JDirector
|
GrantDeferred Stock Units · Derivative | 14.1278 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-005934 · doc4.xml · derivative · entry 1 Shattock Matthew J · CIK 0001531361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,211.0025 Underlying: Common Stock · 14.1278 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 14, 2020 Filed Apr 2, 2020 20:19 UTC |
Fleischer Spencer CDirector
|
GrantDeferred Stock Units · Derivative | 54.537 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-005930 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,535.0375 Underlying: Common Stock · 54.537 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 14, 2020 Filed Jan 5, 2021 21:20 UTC |
Thomas-Graham PamelaDirector
|
GrantDeferred Stock Units · Derivative | 167.3254 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000256 · doc4.xml · derivative · entry 1 Thomas-Graham Pamela · CIK 0001327431 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,186.4218 Underlying: Common Stock · 167.3254 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 14, 2020 Filed Jan 5, 2021 21:20 UTC |
MACKAY A D DAVIDDirector
|
GrantDeferred Stock Units · Derivative | 21.8125 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000255 · doc4.xml · derivative · entry 1 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,413.6513 Underlying: Common Stock · 21.8125 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 14, 2020 Filed Jan 5, 2021 21:20 UTC |
Lee EstherDirector
|
GrantDeferred Stock Units · Derivative | 46.3958 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000254 · doc4.xml · derivative · entry 1 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,260.9407 Underlying: Common Stock · 46.3958 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 14, 2020 Filed Jan 5, 2021 21:20 UTC |
Carmona Richard HDirector
|
GrantDeferred Stock Units · Derivative | 138.9955 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000252 · doc4.xml · derivative · entry 1 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,752.7985 Underlying: Common Stock · 138.9955 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 14, 2020 Filed Jan 5, 2021 21:20 UTC |
Banse AmyDirector
|
GrantDeferred Stock Units · Derivative | 21.8125 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000250 · doc4.xml · derivative · entry 1 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,413.6513 Underlying: Common Stock · 21.8125 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:16 UTC |
Baker JeffVP - CAO & Corp Controller
|
GrantCommon Stock | 1,517 | $164.76 | $249,940.92 |
DisclosureSEC source: 0001225208-20-002171 · doc4.xml · nonDerivative · entry 1 Baker Jeff · CIK 0001699866 · VP - CAO & Corp Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,753 F1 · kind: The Restricted Stock Units will vest on the third anniversary of the grant date. F2 · balance_after: Includes 32 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 22:40 UTC |
Barral Diego JSVP - GM, International
|
SaleCommon Stock | 2,086 | $165.62 | $345,479.57 |
DisclosureSEC source: 0001225208-20-001951 · doc4.xml · nonDerivative · entry 1 Barral Diego J · CIK 0001737080 · SVP - GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,247 F1 · price: This transaction was executed in multiple trades at prices ranging from $165.6170 to $165.6310. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:54 UTC |
Shattock Matthew JDirector
|
GrantDeferred Stock Units · Derivative | 167.7087 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000333 · doc4.xml · derivative · entry 3 Shattock Matthew J · CIK 0001531361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,196.8747 Underlying: Common Stock · 167.7087 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F5 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:54 UTC |
Shattock Matthew JDirector
|
GrantDeferred Stock Units · Derivative | 1,013.0902 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000333 · doc4.xml · derivative · entry 2 Shattock Matthew J · CIK 0001531361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,029.166 Underlying: Common Stock · 1,013.0902 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 22:00 UTC |
MACKAY A D DAVIDDirector
|
GrantDeferred Stock Units · Derivative | 1,013.0902 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000346 · doc4.xml · derivative · entry 3 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,391.8388 Underlying: Common Stock · 1,013.0902 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 22:01 UTC |
MATSCHULLAT ROBERT WDirector
|
GrantDeferred Stock Units · Derivative | 1,013.0902 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000347 · doc4.xml · derivative · entry 5 MATSCHULLAT ROBERT W · CIK 0001127780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,460.2926 Underlying: Common Stock · 1,013.0902 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 22:02 UTC |
Fleischer Spencer CDirector
|
GrantDeferred Stock Units · Derivative | 200.2735 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000348 · doc4.xml · derivative · entry 3 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,480.5005 Underlying: Common Stock · 200.2735 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F5 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 22:02 UTC |
Fleischer Spencer CDirector
|
GrantDeferred Stock Units · Derivative | 1,013.0902 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000348 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,280.227 Underlying: Common Stock · 1,013.0902 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:58 UTC |
Lee EstherDirector
|
GrantDeferred Stock Units · Derivative | 1,013.0902 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000344 · doc4.xml · derivative · entry 5 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,214.5449 Underlying: Common Stock · 1,013.0902 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:57 UTC |
Carmona Richard HDirector
|
GrantDeferred Stock Units · Derivative | 1,013.0902 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000343 · doc4.xml · derivative · entry 5 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,613.803 Underlying: Common Stock · 1,013.0902 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:57 UTC |
WILLIAMS CHRISTOPHER JDirector
|
GrantDeferred Stock Units · Derivative | 186.2919 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000341 · doc4.xml · derivative · entry 3 WILLIAMS CHRISTOPHER J · CIK 0001269949 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,351.0677 Underlying: Common Stock · 186.2919 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F5 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:57 UTC |
WILLIAMS CHRISTOPHER JDirector
|
GrantDeferred Stock Units · Derivative | 1,013.0902 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000341 · doc4.xml · derivative · entry 2 WILLIAMS CHRISTOPHER J · CIK 0001269949 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,164.7758 Underlying: Common Stock · 1,013.0902 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:56 UTC |
WEINER RUSSELL JDirector
|
GrantDeferred Stock Units · Derivative | 167.7087 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000339 · doc4.xml · derivative · entry 3 WEINER RUSSELL J · CIK 0001622458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,879.3171 Underlying: Common Stock · 167.7087 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F5 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:56 UTC |
WEINER RUSSELL JDirector
|
GrantDeferred Stock Units · Derivative | 1,013.0902 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000339 · doc4.xml · derivative · entry 2 WEINER RUSSELL J · CIK 0001622458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,711.6084 Underlying: Common Stock · 1,013.0902 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:55 UTC |
Thomas-Graham PamelaDirector
|
GrantDeferred Stock Units · Derivative | 1,013.0902 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000338 · doc4.xml · derivative · entry 5 Thomas-Graham Pamela · CIK 0001327431 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,019.0964 Underlying: Common Stock · 1,013.0902 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 21:52 UTC |
Banse AmyDirector
|
GrantDeferred Stock Units · Derivative | 1,013.0902 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000332 · doc4.xml · derivative · entry 5 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,391.8388 Underlying: Common Stock · 1,013.0902 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 21:15 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
SaleCommon Stock | 3,326 | $146.18 | $486,187.70 |
DisclosureSEC source: 0001225208-19-014864 · doc4.xml · nonDerivative · entry 2 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 3,048 F1 · price: This transaction was executed in multiple trades at prices ranging from $146.1710 to $146.1780. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 21:15 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
SaleCommon Stock | 725 | $146.34 | $106,092.88 |
DisclosureSEC source: 0001225208-19-014864 · doc4.xml · nonDerivative · entry 1 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,805 Read SEC document |
| November 15, 2019 Filed Jan 3, 2020 21:54 UTC |
Shattock Matthew JDirector
|
GrantDeferred Stock Units · Derivative | 7.3588 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000333 · doc4.xml · derivative · entry 1 Shattock Matthew J · CIK 0001531361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,016.0757 Underlying: Common Stock · 7.3588 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 15, 2019 Filed Jan 3, 2020 22:00 UTC |
MACKAY A D DAVIDDirector
|
GrantDeferred Stock Units · Derivative | 17.2279 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000346 · doc4.xml · derivative · entry 2 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,378.7486 Underlying: Common Stock · 17.2279 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 15, 2019 Filed Jan 3, 2020 22:01 UTC |
MATSCHULLAT ROBERT WDirector
|
GrantDeferred Stock Units · Derivative | 633.329 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000347 · doc4.xml · derivative · entry 4 MATSCHULLAT ROBERT W · CIK 0001127780 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,447.2024 Underlying: Common Stock · 633.329 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 15, 2019 Filed Jan 3, 2020 22:02 UTC |
Fleischer Spencer CDirector
|
GrantDeferred Stock Units · Derivative | 52.6316 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000348 · doc4.xml · derivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,267.1367 Underlying: Common Stock · 52.6316 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 15, 2019 Filed Jan 3, 2020 21:58 UTC |
Lee EstherDirector
|
GrantDeferred Stock Units · Derivative | 44.9135 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000344 · doc4.xml · derivative · entry 4 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,201.4547 Underlying: Common Stock · 44.9135 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 15, 2019 Filed Jan 3, 2020 21:57 UTC |
Carmona Richard HDirector
|
GrantDeferred Stock Units · Derivative | 149.1989 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000343 · doc4.xml · derivative · entry 4 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,600.7127 Underlying: Common Stock · 149.1989 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 15, 2019 Filed Jan 3, 2020 21:57 UTC |
WILLIAMS CHRISTOPHER JDirector
|
GrantDeferred Stock Units · Derivative | 51.7955 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000341 · doc4.xml · derivative · entry 1 WILLIAMS CHRISTOPHER J · CIK 0001269949 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,151.6856 Underlying: Common Stock · 51.7955 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 15, 2019 Filed Jan 3, 2020 21:56 UTC |
WEINER RUSSELL JDirector
|
GrantDeferred Stock Units · Derivative | 26.7862 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000339 · doc4.xml · derivative · entry 1 WEINER RUSSELL J · CIK 0001622458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,698.5181 Underlying: Common Stock · 26.7862 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 15, 2019 Filed Jan 3, 2020 21:55 UTC |
Thomas-Graham PamelaDirector
|
GrantDeferred Stock Units · Derivative | 181.1039 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000338 · doc4.xml · derivative · entry 4 Thomas-Graham Pamela · CIK 0001327431 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,006.0062 Underlying: Common Stock · 181.1039 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| November 15, 2019 Filed Jan 3, 2020 21:52 UTC |
Banse AmyDirector
|
GrantDeferred Stock Units · Derivative | 17.2279 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-000332 · doc4.xml · derivative · entry 4 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,378.7486 Underlying: Common Stock · 17.2279 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.